AMCP strongly supports the passage of the MVP Act. Medicaid beneficiaries are among America's most vulnerable patients. Value-based payment arrangements are a critical tool for promoting patient access to high-quality, affordable care.
AMCP Format for Formulary Submissions — Guidance on Submission of Pre-Approval and Post-Approval Clinical and Economic Information and Evidence, Version 4.1
Originally posted on JMCP on March 31, 2024.
The evidentiary recommendations and guidelines outlined in the AMCP Format are intended for use by manufacturers to communicate clinical and economic evidence and information to HCDMs who make or influence formulary, coverage, policy, and reimbursement decisions for new and existing products. The AMCP Format is guidance, not a mandate. Manufacturers have final discretion on how to communicate information for consideration by HCDMs.
The AMCP Format supports the informed review, assessment, selection, and payment of medical products by:
- Identifying the evidence needed for evaluating the clinical and economic value of medical products.
- Standardizing the synthesis and organization of the evidence and information in a concise living document, known as the “AMCP dossier” or “product dossier,” that evolves with the life cycle of the product from the pre-approval phase through the post-approval period.
- Establishing a framework for the provision of objective and credible clinical and economic information needed by HCDMs.
- Recommending economic analyses and models to project the cost-effectiveness and budgetary impact on the HCDM’s organization and its patient or member population, as well as to assess the overall economic value of an approved product.
- Encouraging a clear and transparent bidirectional communication and sharing process between manufacturers and HCDMs.
Additional Resources
- FormularyDecisions.com
Get easy access to current product information, e-dossiers, and other resources to help you in formulary development.
AMCP Corporate Opportunities
- Launching a product? Let us assist you in crafting a comprehensive plan to support your growth trajectory. Learn more.
- Looking to increase brand awareness? Let us help you find the right AMCP platforms to amplify your message. Learn more.
Related
AMCP supports the Ensuring Community Access to Pharmacist Services Act. This bill will help ensure that Americans can continue to rely on pharmacists as essential partners in pandemic preparedness and response. The ECAPS Act will also improve patient access to tests and treatments by authorizing pharmacists to provide these services and receive reimbursement under Medicare Part B. The ECAPS Act addresses disparities in public health preparedness in medically underserved communities like rural areas by allowing these patients to seek care from their most accessible provider.
AMCP supports the Access to Prescription Digital Therapeutics Act. Expanding coverage of PDTs will improve care for millions of American patients and help standardize reimbursement practices and coding of these therapies across both public and private payers.
Featured News & Resources
See Full Calendar
National Meetings
Midwest AMCP Chicago Day of Education
National Meetings
Mountain West Pharmacy Summit
Other Events
Northeast Day of Education
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
